Stroke Unit, University Hospital La Timone, AP-HM, Marseille, France (E.D., C.S., L.S.).
Centre de recherche en CardioVasculaire et Nutrition (C2VN), Marseille, France (E.D., C.S., J.-C.M., L.S.).
Stroke. 2024 Jul;55(7):1818-1829. doi: 10.1161/STROKEAHA.124.047156. Epub 2024 May 21.
The dramatic clinical improvement offered by mechanical thrombectomy raised questions about the relevance of prior intravenous thrombolysis in large-vessel occlusion strokes. Hence, studying intravenous thrombolysis susceptibility and its dependence on thrombus composition is crucial. We used an observational proteomic study of whole thrombi retrieved by mechanical thrombectomy to identify factors associated with fibrin content and fibrinolytic activity (FA).
In 104 stroke patients, the thrombi proteome was established by mass spectrometry coupled to liquid chromatography. FA was estimated in clots both outside (FA) by measuring D-dimer levels at the blood-thrombus interface and inside (FA) by evaluating the ratio of fibrinogen α to its plasmin-cleaved forms using proteomics coupled with protein electrophoresis. The factors associated with fibrin content, FA, and FA were determined by intravenous thrombolysis-adjusted linear regression.
FA (<0.0001) and FA (=0.0147) were driven by recombinant tissue-type plasminogen activator (r-tPA) administration (47/104) and thrombus composition. Indeed, FA was greater with fibrin-rich than erythrocyte-rich thrombi, presumably because of more (r)tPA substrates. Thus, FA was increased with cardioembolic thrombi (72/104), which are rich in fibrin (=0.0300). Opposite results were found inside the thrombus, suggesting that (r)tPA penetrability was hampered by the density of the fibrinous cap. Moreover, blood cells had a strong impact on thrombus structure and susceptibility to (r)tPA. Indeed, fibrin content was negatively associated with erythrocyte-specific proteins in the thrombus, admission hematocrit (=0.0139), and hemoglobin level (=0.0080), which underlines the key role of erythrocytes in thrombus composition. Also, an increased number of neutrophils impaired FA (=0.0225), which suggests that their aggregation around the thrombus prevented the (r)tPA attack. Only FA was significantly associated with reduced thrombus weight (=0.0310), increased recanalization rate (=0.0150), good clinical outcome (=0.0480), and reduced mortality (=0.0080).
Proteomics can offer new insights into the close relationship between thrombus composition and susceptibility to fibrinolysis, paving the way for new adjuvant therapies.
机械血栓切除术带来的显著临床改善引发了关于大血管闭塞性卒中患者静脉溶栓治疗的相关性的疑问。因此,研究静脉溶栓的敏感性及其对血栓成分的依赖性至关重要。我们使用机械血栓切除术获取的全血栓的观察性蛋白质组学研究来确定与纤维蛋白含量和纤维蛋白溶解活性(FA)相关的因素。
在 104 名卒中患者中,通过质谱法与液相色谱法建立血栓的蛋白质组学。通过测量血栓-血液界面处 D-二聚体水平来评估血栓外部(FA)的纤维蛋白溶解活性,并通过使用蛋白质组学与蛋白质电泳相结合来评估纤维蛋白原α与其纤溶酶裂解形式的比值来评估血栓内部(FA)的纤维蛋白溶解活性。通过静脉溶栓调整的线性回归确定与纤维蛋白含量、FA 和 FA 相关的因素。
FA(<0.0001)和 FA(=0.0147)受重组组织型纤溶酶原激活剂(r-tPA)给药(47/104)和血栓成分的驱动。事实上,富含纤维蛋白的血栓比富含红细胞的血栓具有更高的 FA(可能是因为有更多的(r)tPA 底物)。因此,富含纤维蛋白的心源性栓塞性血栓(72/104)的 FA 更高。相反,在血栓内部则发现了相反的结果,这表明(r)tPA 的穿透性受到纤维蛋白帽密度的阻碍。此外,血细胞对血栓结构和对(r)tPA 的敏感性有很大影响。事实上,纤维蛋白含量与血栓中红细胞特异性蛋白呈负相关(=0.0139),与血红蛋白水平呈负相关(=0.0080),这突出了红细胞在血栓成分中的关键作用。此外,中性粒细胞数量的增加会损害 FA(=0.0225),这表明它们在血栓周围聚集会阻止(r)tPA 的攻击。只有 FA 与血栓重量降低(=0.0310)、再通率增加(=0.0150)、临床结局良好(=0.0480)和死亡率降低(=0.0080)显著相关。
蛋白质组学可以为血栓成分与纤溶敏感性之间的密切关系提供新的见解,为新的辅助治疗方法铺平道路。